Canopy Growth Announces Executive and Board Changes

Ticker: CGC · Form: 8-K · Filed: 2024-08-16T00:00:00.000Z

Sentiment: neutral

Topics: executive-changes, board-changes, disclosure

TL;DR

Canopy Growth shakes up exec team and board, filing details new comp plans.

AI Summary

Canopy Growth Corporation announced on August 15, 2024, a series of executive changes and the appointment of new directors. The company also disclosed compensatory arrangements for certain officers and provided a Regulation FD disclosure. The filing includes financial statements and exhibits.

Why It Matters

Changes in executive leadership and board composition can signal shifts in company strategy and future performance.

Risk Assessment

Risk Level: medium — Executive and board changes can introduce uncertainty regarding future strategy and operational stability.

Key Players & Entities

FAQ

What specific executive positions were affected by the changes?

The filing indicates changes related to 'Departure of Directors or Certain Officers' and 'Appointment of Certain Officers', but does not specify the exact positions in the provided text.

Were any new directors elected to the board?

Yes, the filing lists 'Election of Directors' as an item of information, indicating new directors were appointed.

What is the nature of the 'Compensatory Arrangements of Certain Officers' disclosed?

The filing mentions 'Compensatory Arrangements of Certain Officers' as a disclosed item, but the specific details of these arrangements are not provided in the excerpt.

What is the significance of the 'Regulation FD Disclosure'?

Regulation FD (Fair Disclosure) ensures that material non-public information is broadly disseminated to the public, preventing selective disclosure.

Where is Canopy Growth Corporation's principal executive office located?

Canopy Growth Corporation's principal executive offices are located at 1 Hershey Drive, Smiths Falls, Ontario, K7A 0A8.

From the Filing

0001104659-24-090360.txt : 20240816 0001104659-24-090360.hdr.sgml : 20240816 20240816085316 ACCESSION NUMBER: 0001104659-24-090360 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240815 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240816 DATE AS OF CHANGE: 20240816 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Canopy Growth Corp CENTRAL INDEX KEY: 0001737927 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38496 FILM NUMBER: 241214247 BUSINESS ADDRESS: STREET 1: 1 HERSHEY DRIVE CITY: SMITH FALLS STATE: A6 ZIP: K7A0A8 BUSINESS PHONE: 855-558-9333 MAIL ADDRESS: STREET 1: 1 HERSHEY DRIVE CITY: SMITH FALLS STATE: A6 ZIP: K7A0A8 8-K 1 tm2421886d1_8k.htm FORM 8-K false 0001737927 Canopy Growth Corp 00-0000000 0001737927 2024-08-15 2024-08-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       FORM 8-K         CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): August 15, 2024       Canopy Growth Corporation (Exact name of registrant as specified in its charter)       Canada   001-38496   N/A (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   1 Hershey Drive Smiths Falls , Ontario K7A 0A8 (Address of principal executive offices) (Zip Code)   ( 855 ) 558-9333 (Registrant’s telephone number, including area code)   Not Applicable (Former name or former address, if changed since last report)       Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class Trading Symbol(s) Name of each exchange on which registered Common Shares, no par value CGC Nasdaq Global Select Market   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company     ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨             Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.   On August 15, 2024, Canopy Growth Corporation (the “Company”) entered into a Mutual Separation Agreement (the “Separation Ag

View on Read The Filing